共 50 条
- [32] Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidence [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1037 - 1046
- [33] Crizotinib in the Treatment of Non-Small-Cell Lung Cancer [J]. CLINICAL LUNG CANCER, 2013, 14 (05) : 473 - 480
- [34] Gefitinib for non-small-cell lung cancer treatment [J]. EXPERT OPINION ON DRUG SAFETY, 2011, 10 (06) : 987 - 996
- [36] Bevacizumab in the treatment of non-small-cell lung cancer [J]. ONCOGENE, 2007, 26 (25) : 3691 - 3698
- [37] Gefitinib for the treatment of non-small-cell lung cancer [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (08) : 1343 - 1357
- [39] Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21): : 2018 - 2028
- [40] Selumetinib in the treatment of non-small-cell lung cancer [J]. FUTURE ONCOLOGY, 2016, 12 (22) : 2545 - 2560